Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Settlement For B Vitamins And Vascular Disease Reached - Nutraceuticals World
Market Updates

Settlement For B Vitamins And Vascular Disease Reached

The U.S. District Court for the District of Columbia on April 2, 2001 dismissed the complaint in Whitaker v. Thompson, which involved a challenge to an FDA decision regarding a dietary supplement health claim relating intake of B vitamins and risk of vascular disease. The dismissal followed an agreement reached between FDA and the plaintiffs regarding the use of a disclaimer with the health claim at issue. As part of its agreement, FDA stated its intention to exercise enforcement discretion to permit the plaintiffs to place the following statement on labels in labeling of their dietary supplements containing folic acid, vitamin B6 and B12:

“As part of a well-balanced diet that is low in saturated fat and cholesterol, folic acid, vitamin B6 and vitamin B12 may reduce the risk of vascular disease.”*

*FDA evaluated the above claim and found that, while it is known that diets low in saturated fat and cholesterol reduce the risk of heart disease and other vascular diseases, the evidence in support of the above claim is inconclusive.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters